Biotech Values

[DewDiligence]

MNTA Insider Shareholdings

[Removed entry for director Robert Langer, who is retiring from
the BoD effective 6/10/09 (the date of MNTA’s annual meeting).
The tallies below include both ordinary and restricted shares
and both vested and non-vested options.]

 
 Executive Officers 
 *Craig Wheeler, CEO        416,562 shares   575,000 options 
 G. Venkataraman, SVP R&D   465,440 shares   163,200 options 
 Steven Brugger, COO        280,189 shares   185,556 options 
 *John Bishop, SVP Pharma    44,937 shares   186,163 options 
 Bruce Leicher, Gen Counsel† 31,650 shares   113,300 options 
 James Roach, CMO‡            9,500 shares   181,500 options 
 *Richard Shea, CFO          34,469 shares   225,450 options 
 =====                    =========        ========= 
 7 Executive Officers     1,282,747 shares 1,630,169 options 
  
  
 Non-executive Directors 
 John Clarke                 77,123 shares    96,000 options 
 Alan Crane                 578,602 shares    73,600 options 
 Marsha Fanucci                   0 shares    96,000 options 
 Peter Hutt                  67,863 shares   171,500 options 
 *Ram Sasisekharan          406,344 shares    96,000 options 
 *Bennett Shapiro             7,000 shares   110,450 options 
 Elizabeth Stoner                 0 shares    49,200 options 
 James Sulat††                    0 shares    30,000 options 
 =====                    =========          ======= 
 8 Non-executive Dirctrs  1,136,932 shares   722,750 options 
  
  
 All Officers/Directors   2,419,679 shares 2,352,919 options  
  
 *10b5-1 selling plan in effect. 
 †Hired 7/24/08. 
 ‡Hired 2/26/08. 
 ††Joined BoD as Chairman 6/5/08.